Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Meningococcal Immunization”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00463437
What this trial is testing

Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines

Who this might be right for
Hepatitis BAcellular PertussisTetanus+3 more
GlaxoSmithKline 1,437
Testing effectiveness (Phase 2)Study completedNCT00381615
What this trial is testing

Prevention, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study

Who this might be right for
Healthy
Novartis Vaccines 147
Post-approval studies (Phase 4)Study completedNCT01119482
What this trial is testing

Study on the Impact of Vaccination With a Conjugate Vaccine on Meningococcal Carriage

Who this might be right for
Meningitis
London School of Hygiene and Tropical Medicine 33,000
Not applicableUnknownNCT04239430
What this trial is testing

Propositive (Protecting Positive People From Meningococcal Infection) Follow-up Study

Who this might be right for
HIV/AIDSMeningococcal Disease
St George's, University of London 55
Testing effectiveness (Phase 2)Study completedNCT00356369
What this trial is testing

Study in Adolescents/Adults to Evaluate Non-inferiority&Persistence up to 5 Years of GSK Bio MenACWY Conjugate Vaccine

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 500
Testing effectiveness (Phase 2)Study completedNCT06128733
What this trial is testing

Study of an Investigational Pentavalent Meningococcal ABCYW Vaccine in Adults and Adolescents

Who this might be right for
Meningococcal ImmunisationHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 1,215
Testing effectiveness (Phase 2)Study completedNCT01026974
What this trial is testing

Extension Study Evaluating Antibody Persistence and Safety, Tolerability and Immunogenicity of a Booster Dose of Novartis rMenB±OMV NZ Vaccine in Healthy UK Children Who Previously Received Three Doses of the Same Vaccine

Who this might be right for
Meningococcal Disease
Novartis Vaccines 120
Testing effectiveness (Phase 2)Study completedNCT00661557
What this trial is testing

Comparison of GSK134612 in Subjects Previously Vaccinated Against Meningococcal Disease Versus Non-vaccinated Subjects

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 271
Post-approval studies (Phase 4)Study completedNCT02446691
What this trial is testing

Evaluation of Antibody Persistence Following 4 MenACWY Vaccinations

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 128
Early research (Phase 1)Study completedNCT06165276
What this trial is testing

A Phase I, Randomized, Modified Single-blind, Active-controlled (Infants Only), Four-stage, Step-down, Comparative, Multi-center Study

Who this might be right for
Meningococcal Immunization
Sanofi Pasteur, a Sanofi Company 285
Post-approval studies (Phase 4)Study completedNCT01896596
What this trial is testing

Hepatitis B Vaccination in Infants

Who this might be right for
Meningococcal DiseasePneumococcal DiseaseHaemophilus Influenzae Serotype b Disease+2 more
Public Health England 300
Large-scale testing (Phase 3)Study completedNCT00317109
What this trial is testing

Study to Asses DTPw-HBV/Hib at 15-18 Months (m) and Mencevax™ ACW at 24 to 30 m in Primed Subjects

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 168
Testing effectiveness (Phase 2)Study completedNCT00774384
What this trial is testing

Regulation of Mucosal Immune Response to Systemic MenB Vaccine

Who this might be right for
Meningococcal Infections
University Hospitals Bristol and Weston NHS Foundation Trust 9
Testing effectiveness (Phase 2)Study completedNCT00780806
What this trial is testing

Safety And Blood Collection Study Of Meningococcal B Rlp2086 Vaccine In Adults

Who this might be right for
Meningitis, Meningococcal
Wyeth is now a wholly owned subsidiary of Pfizer 60
Testing effectiveness (Phase 2)Study completedNCT01239043
What this trial is testing

Antibody Persistence and Response to Re-vaccination With Either Menactra® or Menomune® 3 Years After Initial Vaccination

Who this might be right for
MeningitisMeningococcal MeningitisMeningococcal Infections
Sanofi 139
Testing effectiveness (Phase 2)Study completedNCT00137917
What this trial is testing

Immunogenicity & Safety Study of a Meningococcal Serogroup B Vaccine Given in a 3 Dose Schedule to Healthy Adolescents Aged 12-18 Yrs

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 478
Not applicableStudy completedNCT03824093
What this trial is testing

High and Low Resource Interventions to Promote HPV Vaccines

Who this might be right for
Human Papilloma VirusTdap - Tetanus, Diphtheria and Acellular Pertussis VaccinationMeningitis, Meningococcal+2 more
Children's Mercy Hospital Kansas City 225
Testing effectiveness (Phase 2)Study completedNCT00433914
What this trial is testing

Safety, Tolerability and Immunogenicity of Two Different Formulations of Meningococcal B Recombinant Vaccine, When Administered to Healthy Infants

Who this might be right for
Meningococcal Disease
Novartis Vaccines 60
Large-scale testing (Phase 3)Study completedNCT00345579
What this trial is testing

Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 2, 4, 6 and 12 to 15 Months of Age

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 4,432
Large-scale testing (Phase 3)Study completedNCT05794230
What this trial is testing

Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South Africa

Who this might be right for
Meningococcal ImmunisationHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 1,528
Next Page